For: | Seddik H, Benass J, Berrag S, Sair A, Berraida R, Boutallaka H. Optimized sequential therapy vs 10- and 14-d concomitant therapy for eradicating Helicobacter pylori: A randomized clinical trial. World J Gastroenterol 2024; 30(6): 556-564 [PMID: 38463026 DOI: 10.3748/wjg.v30.i6.556] |
---|---|
URL: | https://www.wjgnet.com/2220-3192/full/v30/i6/556.htm |
Number | Citing Articles |
1 |
Tianlian Yan, Jinghua Wang, Renke Zhu, Dan Ma, Jianguo Gao, Jiewei Wang, Ye Chen, Kefang Sun, Qing Gu, Lan Li. Vonoprazan improves the efficacy of bismuth quadruple therapy containing doxycycline and metronidazole as first-line Helicobacter pylori treatment in penicillin-allergic patients: a randomized controlled trial. Journal of Antimicrobial Chemotherapy 2025; 80(4): 927 doi: 10.1093/jac/dkae467
|
2 |
Jad Chidiac, Reine-Marie Kahwaji, Souheil Hallit, Yara Yazbeck, Bassem Akiki, Charbel Yazbeck. A Randomized, Prospective and Crossover Study, Comparing the Eradication Rate After 10 Days of Concomitant Therapy to Bismuth Quadruple Therapy Among a Sample of the Lebanese Population. Current Therapeutic Research 2025; 102: 100791 doi: 10.1016/j.curtheres.2025.100791
|